<article xmlns="http://dtd.nlm.nih.gov/2.0/xsd/archivearticle" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://dtd.nlm.nih.gov/2.0/xsd/archivearticle http://dtd.nlm.nih.gov/2.0/xsd/archivearticle.xsd" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Vascul Pharmacol</journal-id>
      <journal-title-group>
        <journal-title>Vascular Pharmacology</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">1537-1891</issn>
      <issn pub-type="epub">1879-3649</issn>
      <publisher>
        <publisher-name>Elsevier Science</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmc">3191278</article-id>
      <article-id pub-id-type="pmid">20601125</article-id>
      <article-id pub-id-type="publisher-id">VPH5844</article-id>
      <article-id pub-id-type="doi">10.1016/j.vph.2010.06.002</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Evidence both L-type and non-L-type voltage-dependent calcium channels contribute to cerebral artery vasospasm following loss of NO in the rat</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>McNeish</surname>
            <given-names>A.J.</given-names>
          </name>
          <xref rid="aff2" ref-type="aff">b</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Altayo</surname>
            <given-names>Francesc Jimenez</given-names>
          </name>
          <xref rid="aff1" ref-type="aff">a</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Garland</surname>
            <given-names>C.J.</given-names>
          </name>
          <email>christopher.garland@pharm.ox.ac.uk</email>
          <xref rid="aff1" ref-type="aff">a</xref>
          <xref rid="cor1" ref-type="corresp">⁎</xref>
        </contrib>
      </contrib-group>
      <aff id="aff1"><label>a</label>Department of Pharmacology, University of Oxford, Mansfield Road Oxford OX1 3QT, United Kingdom</aff>
      <aff id="aff2"><label>b</label>Department of Pharmacy and Pharmacology, University of Bath, BA2 7AY, United Kingdom</aff>
      <author-notes>
        <corresp id="cor1"><label>⁎</label>Corresponding author. Tel.: + 44 1865 281119; fax: + 44 1865 271853. <email>christopher.garland@pharm.ox.ac.uk</email></corresp>
      </author-notes>
      <pub-date pub-type="pmc-release">
        <month>9</month>
        <year>2010</year>
      </pub-date>
      <!-- PMC Release delay is 0 months and 0 days and was based on the
							<pub-date pub-type="ppub"/>. -->
      <pub-date pub-type="ppub">
        <month>9</month>
        <year>2010</year>
      </pub-date>
      <volume>53</volume>
      <issue>3-4</issue>
      <fpage>151</fpage>
      <lpage>159</lpage>
      <history>
        <date date-type="received">
          <day>21</day>
          <month>4</month>
          <year>2010</year>
        </date>
        <date date-type="rev-recd">
          <day>1</day>
          <month>6</month>
          <year>2010</year>
        </date>
        <date date-type="accepted">
          <day>12</day>
          <month>6</month>
          <year>2010</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>© 2010 Elsevier Inc.</copyright-statement>
        <copyright-year>2010</copyright-year>
        <copyright-holder>Elsevier Inc.</copyright-holder>
        <license>
          <license-p>This document may be redistributed and reused, subject to <ext-link ext-link-type="uri" xlink:href="http://www.elsevier.com/wps/find/authorsview.authors/supplementalterms1.0">certain conditions</ext-link>.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>We recently found block of NO synthase in rat middle cerebral artery caused spasm, associated with depolarizing oscillations in membrane potential (E<sub>m</sub>) similar in form but faster in frequency (<italic>circa</italic> 1 Hz) to vasomotion. T-type voltage-gated Ca<sup>2+</sup> channels contribute to cerebral myogenic tone and vasomotion, so we investigated the significance of T-type and other ion channels for membrane potential oscillations underlying arterial spasm. Smooth muscle cell membrane potential (E<sub>m</sub>) and tension were measured simultaneously in rat middle cerebral artery. NO synthase blockade caused temporally coupled depolarizing oscillations in cerebrovascular E<sub>m</sub> with associated vasoconstriction. Both events were accentuated by block of smooth muscle BK<sub>Ca</sub>. Block of T-type channels or inhibition of Na<sup>+</sup>/K<sup>+</sup>-ATPase abolished the oscillations in E<sub>m</sub> and reduced vasoconstriction. Oscillations in E<sub>m</sub> were either attenuated or accentuated by reducing [Ca<sup>2+</sup>]<sub>o</sub> or block of K<sub>V</sub>, respectively. TRAM-34 attenuated oscillations in both E<sub>m</sub> and tone, apparently independent of effects against K<sub>Ca</sub>3.1. Thus, rapid depolarizing oscillations in E<sub>m</sub> and tone observed after endothelial function has been disrupted reflect input from T-type calcium channels in addition to L-type channels, while other depolarizing currents appear to be unimportant. These data suggest that combined block of T and L-type channels may represent an effective approach to reverse cerebral vasospasm.</p>
      </abstract>
      <abstract abstract-type="graphical">
        <title>Graphical abstract</title>
        <fig id="d30e326" position="anchor">
          <graphic xlink:href="fx1"/>
        </fig>
      </abstract>
      <kwd-group>
        <title>Keywords</title>
        <kwd>Cerebral vasospasm</kwd>
        <kwd>K-channels</kwd>
        <kwd>T-type calcium channels</kwd>
        <kwd>Nitric oxide</kwd>
        <kwd>Endothelial cell dysfunction</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec>
      <label>1</label>
      <title>Introduction</title>
      <p>Cerebral arteries operate in a dynamic state of partial constriction (myogenic tone), providing the capacity to constrict or relax in response to changing levels of intraluminal pressure, shear stress and nerve activity. Myogenic tone is an intrinsic property of the smooth muscle, helping maintain constant total cerebral blood flow and adapting blood flow locally to meet metabolic demand. Myogenic constriction is driven primarily by membrane depolarization leading to Ca<sup>2+</sup> influx (<xref rid="bib8 bib23" ref-type="bibr">Davis and Hill, 1999; Hill et al., 2001</xref>), possibly with a contribution via stretch-activated calcium sensitization (<xref rid="bib58" ref-type="bibr">Schubert et al., 2008</xref>). Myogenic tone is often superimposed by vasomotion in the form of synchronised oscillations in smooth muscle cell membrane potential (Em), Ca<sup>2+</sup> and tension. Although the physiological function of vasomotion in general is unclear, it may help to maintain a constant blood supply in many tissues, including the brain (<xref rid="bib17 bib20" ref-type="bibr">Gustafsson, 1993; Haddock and Hill, 2005</xref>).</p>
      <p>One key influence of basal NO release in the middle cerebral artery appears to be suppression of both myogenic tone (<xref rid="bib14 bib53 bib68" ref-type="bibr">Golding et al., 2001; Peng et al., 1998; Zimmermann et al., 1997</xref>) and vasomotion (<xref rid="bib9 bib19" ref-type="bibr">Dirnagl et al., 1993; Haddock and Hill, 2002</xref>). This influence appears largely due to activation of BK<sub>Ca</sub> (<xref rid="bib5 bib37 bib67" ref-type="bibr">Brayden and Nelson, 1992; Mandala et al., 2007; Yuill et al., 2010</xref>). So block of NO generation and/or BK<sub>Ca</sub> provides a means to mimic an aspect of endothelial dysfunction that is an early feature of cardiovascular disease, including disease conditions that predispose to vasospasm (<xref rid="bib28 bib63" ref-type="bibr">Jewell et al., 2004; Vanhoutte et al., 2009</xref>). These conditions will also mimic the loss of NO observed after subarachnoid haemorrhage, where scavenging of NO by haemoglobin (<xref rid="bib40" ref-type="bibr">Martin et al., 1985</xref>) causes profound vasospasm (<xref rid="bib61" ref-type="bibr">Toda et al., 1991</xref>). Significantly, enhanced vasomotion (or vasospasm) can lead to a reduction of cerebral capillary blood flow and thus compromise of neuronal function (<xref rid="bib3 bib56" ref-type="bibr">Biswal and Hudetz, 1996; Pluta, 2005</xref>).</p>
      <p>Several mechanisms, including the rho-kinase pathway, can contribute to the development and maintenance of constriction in smooth muscle, alongside calcium entry. However, in many vascular beds, including the cerebral vasculature changes in smooth muscle intracellular Ca<sup>2+</sup> ([Ca<sup>2+</sup>]<sub>i</sub>) concentration is critical for myogenic tone and vasomotion (<xref rid="bib19 bib20 bib67" ref-type="bibr">Haddock and Hill, 2002, 2005; Yuill et al., 2010</xref>). [Ca<sup>2+</sup>]<sub>i</sub> increase involves release from intracellular stores and entry from the extracellular space via voltage-gated Ca<sup>2+</sup> channels and non-selective cation channels, such as transient receptor potential channels (TRPC). Ca<sup>2+</sup> influx through voltage-gated Ca<sup>2+</sup> channels (VGCC) leads to global increases in smooth muscle cell [Ca<sup>2+</sup>]<sub>i</sub> and constriction, and high voltage activated (L-type) Ca<sup>2+</sup> channels appear central in this sequence (<xref rid="bib43 bib47 bib51" ref-type="bibr">McCarron et al., 1997; Moosmang et al., 2003; Nelson et al., 1990</xref>). These channels are expressed widely in vascular smooth muscle and their open probability increases over a physiologically relevant range (circa −50 to −30 mV) (<xref rid="bib35 bib59" ref-type="bibr">Lacinova, 2005; Smirnov and Aaronson, 1992</xref>). Low voltage activated or T-type Ca<sup>2+</sup> channels are also expressed in vascular smooth muscle of resistance arteries (<xref rid="bib4 bib7 bib34 bib50 bib55" ref-type="bibr">Braunstein et al., 2008; Clozel et al., 1997; Kuo et al., 2008; Navarro-Gonzalez et al., 2009; Perez-Reyes, 2003</xref>). But although they are normally active in the range <italic>circa</italic> −60 to −40 mV, the characteristic rapid inactivation of these channels argues against a significant role at physiologically relevant membrane potentials in the vasculature. Despite this, they have been implicated in the maintenance of vascular tone in a variety of arteries, including rat cremaster (<xref rid="bib62" ref-type="bibr">VanBavel et al., 2002</xref>), rat basilar (<xref rid="bib50" ref-type="bibr">Navarro-Gonzalez et al., 2009</xref>) and middle cerebral (<xref rid="bib36" ref-type="bibr">Lam et al., 1998</xref>) arteries, and direct measurements have shown high voltage activated but nifedipine-insensitive Ca<sup>2+</sup> currents, pharmacologically indistinguishable from T-type currents, in both guinea-pig and rat terminal mesenteric arteries (<xref rid="bib17 bib48 bib49" ref-type="bibr">Gustafsson, 1993; Morita et al., 1999; Morita et al., 2002</xref>).</p>
      <p>We recently reported that middle cerebral arteries develop intense and sustained constriction, associated with a very rapid form of vasomotion, when NOS and/or BK<sub>Ca</sub> channels were blocked, to mimic endothelial dysfunction. Furthermore, both constriction and vasomotion depended on calcium entry via VGCCs and the oscillations in E<sub>m</sub> were temporally linked to changes in smooth muscle [Ca<sup>2+</sup>]<sub>i</sub> (<xref rid="bib67" ref-type="bibr">Yuill et al., 2010</xref>). The temporally linked oscillations in E<sub>m</sub>, [Ca<sup>2+</sup>]<sub>i</sub> and tension were similar to the widely described phenomenon of vasomotion, but displayed a much higher frequency (∼ 1 Hz as opposed to ∼ 0.1–0.2 Hz, <xref rid="bib67" ref-type="bibr">Yuill et al., 2010</xref>). The intense “vasospastic vasomotion” was reversed by inhibition L-type Ca<sup>2+</sup> channels and clearly involved a complex action of NO that appeared to include stimulation of BK<sub>Ca</sub> channels and a cGMP-independent closure of VGCCs (<xref rid="bib67" ref-type="bibr">Yuill et al., 2010</xref>). However, although a central role for VGCC, NO and BK<sub>Ca</sub> was apparent, the importance of other ionic currents that might contribute to the rapid depolarizing oscillations was unclear.</p>
      <p>Thus, the aim of the present study was to characterize the ionic mechanisms responsible for rhythmic oscillations in E<sub>m</sub> and tension in rat isolated middle cerebral arteries following inhibition of BK<sub>Ca</sub> channels and NOS. We probed channels that may lead to both depolarization (calcium, sodium and chloride channels) and repolarization (potassium channels). Our data suggest a novel role for both smooth muscle T-type Ca<sup>2+</sup> channels and several potassium conductances in the both “vasospastic vasomotion” and the underlying maintenance of vasoconstriction.</p>
    </sec>
    <sec sec-type="materials|methods">
      <label>2</label>
      <title>Materials and methods</title>
      <sec>
        <label>2.1</label>
        <title>Animals and tissue isolation</title>
        <p>Male Wistar rats (200–250 g) were killed by cervical dislocation followed by decapitation, following institutional guidelines for animal welfare and schedule 1 of the Animals (scientific procedures) Act 1986. The brain was removed and immediately placed in ice-cold Krebs solution. Segments of the middle cerebral artery (∼ 2 mm long) were dissected and stored in ice-cold Krebs for use within 30 min, with similar size vessels used in all experimental groups.</p>
      </sec>
      <sec>
        <label>2.2</label>
        <title>Experimental protocols</title>
        <p>Segments of middle cerebral artery (internal diameter ∼ 150 μm) were mounted in a Mulvany–Halpern myograph (model 400A, Danish Myotechnology) in Krebs solution containing (mM): NaCl, 118.0, NaCO<sub>3</sub>, 24; KCl, 3.6; MgSO<sub>4</sub>·7H<sub>2</sub>O, 1.2; glucose, 11.0; CaCl<sub>2</sub>, 2.5; gassed with 20% O<sub>2</sub>, 5% CO<sub>2</sub> and balance N<sub>2</sub> and maintained at 37 °C. After equilibration for 20 min, vessels were tensioned to 1–1.5 mN (approximates wall tension at 60 mmHg). Smooth muscle tension was recorded with an isometric force transducer and Powerlab software (ADI, Australia). Vessel viability was assessed by addition of exogenous K<sup>+</sup> (15–55 mM, total K<sup>+</sup> concentration); only vessels developing tension of ≥ 3 mN were used, following this Endothelial cell viability was assessed by the ability of the protease activated receptor 2 activating peptide; SLIGRL (20 μM) (<xref rid="bib1" ref-type="bibr">Alexander et al., 2008</xref>) to relax U46619 induced tone (100 nM) by ≥ 75%, vessels with less relaxation were discarded. In some experiments, endothelial cells were removed by gently rubbing the luminal surface with a human hair; subsequent relaxation of &lt; 15% to SLIGRL (20 μM) was considered as successful removal and further abrasion often lead to damage of smooth muscle cells.</p>
        <p>L-NAME (100 μM), indomethacin (10 μM) and iberiotoxin (100 nM) were added throughout the experiment (to block NO synthase (NOS), cyclooxygenase and BK<sub>Ca</sub> channels, respectively), unless otherwise stated. In combination, these drugs gave a robust and sustained constriction (similar to vasospasm), and an associated rapid vasomotion. Similar responses were recorded in each case after inhibition of NOS alone, but vasomotion was more variable between preparations. Indomethacin had no effect on oscillations, but was included in the experimental cocktail to minimize any potential for confounding thromboxane signaling after NOS inhibition (Benyo et al., 1998; <xref rid="bib45" ref-type="bibr">McNeish and Garland, 2007</xref>). Recordings were assessed in the presence of: the T-type (mibefradil 100 nM and NNC 55-0396 300 nM) and L-type (nifedipine 1 μM) Ca<sup>2+</sup>channel blockers, the K<sub>Ca</sub> channel blockers, apamin (K<sub>Ca</sub>2.3 (SK<sub>Ca</sub>), 50 nM), TRAM-34 (K<sub>Ca</sub>3.1 (IK<sub>Ca</sub>), 1 μM), iberiotoxin (BK<sub>Ca</sub>, K<sub>Ca</sub>1.1, 100 nM) and charybdotoxin (K<sub>Ca</sub>3.1, B<sub>Ca</sub>, 100 nM), the K<sub>IR</sub> channel inhibitors BaCl<sub>2</sub> (30 μM) and CsCl<sub>2</sub> (10 mM), the Na<sup>+</sup>/K<sup>+</sup>-ATPase inhibitor, ouabain (1 μM) and the voltage-gated K<sup>+</sup> channel inhibitor, 4-aminopyridine (4-AP, 3 mM). Papaverine (150 μM) was added at the end of each experiment to assess overall tone. All blocking drugs were incubated for at least 20 min before data was recorded to ensure maximal effect. In most experiments smooth muscle membrane potential (E<sub>m</sub>) and tension were measured simultaneously as previously described, using glass microelectrodes (filled with 2 M KCl; tip resistance, 80–120 MΩ) to measure E<sub>m</sub> (<xref rid="bib12" ref-type="bibr">Garland and McPherson, 1992</xref>).</p>
      </sec>
      <sec>
        <label>2.3</label>
        <title>Data analysis and statistical procedures</title>
        <p>Results are expressed as the mean ± s.e. mean of <italic>n</italic> animals. Tension values are given in mN (always per 2 mm segment) and E<sub>m</sub> as mV. During the vasospastic vasomotion E<sub>m</sub> is expressed as the mean E<sub>m</sub> over a random 10 s period of the rapid vasomotion where possible we have also reported the size of the depolarizing oscillations in mV. Vasodilatation is expressed as percentage reduction of the total vascular tone (myogenic tone plus vasoconstrictor response induced by either U46619 or the combination of L-NAME and iberiotoxin, as appropriate), quantified by relaxation with papaverine (150 μM). Graphs were drawn and comparisons made using either Student's t-test, or one-way ANOVA with Tukey's post-hoc test using Prism software (Graphpad, USA). P ≤ 0.05 was considered significant.</p>
      </sec>
      <sec>
        <label>2.4</label>
        <title>Drugs, chemicals, reagents and other materials</title>
        <p>Exogenous K<sup>+</sup> was added as an isotonic physiological salt solution in which all the NaCl was replaced with an equivalent amount of KCl. Concentrations of K<sup>+</sup> used are expressed as final bath concentration. L-NAME (N<sup>G</sup>-nitro-<sc>l</sc>-arginine methyl ester), indomethacin, mibefradil, NNC 55-0396, nifedipine, barium chloride, cesium chloride, ouabain, 4-aminopyridine and papaverine were all obtained from Sigma (Poole, U.K.). U46619 (9,11-Dideoxy-11α,9α-epoxymethanoprostaglandin F2α) was from Calbiochem (UK). Apamin, charybdotoxin, iberiotoxin and tetrodotoxin from Latoxan (Valence, France). SLIGRL (serine–leucine–isoleucine–glycine–arginine–leucine–NH2) from Auspep (Parkville, Australia). TRAM-34 was a generous gift from Dr H. Wulff (University of California, Davis). All stock solutions were dissolved in distilled water except SLIGRL and charybdotoxin, dissolved in 0.9% NaCl, U46619 and TRAM-34, dissolved in dimethylsulfoxide (DMSO), nifedipine, dissolved in ethanol, and indomethacin which was dissolved in Na<sub>2</sub>CO<sub>3</sub> (2%); vehicle controls were performed for drugs dissolved in DMSO ethanol and Na<sub>2</sub>CO<sub>3</sub>. All nomenclature conforms to the BJP guide to receptors and ion channels (<xref rid="bib1" ref-type="bibr">Alexander et al., 2008</xref>).</p>
      </sec>
    </sec>
    <sec>
      <label>3</label>
      <title>Results</title>
      <sec>
        <label>3.1</label>
        <title>Effect of inhibiting Nitric oxide synthase and BK<sub>Ca</sub> on E<sub>m</sub> and tension.</title>
        <p>Rat middle cerebral arteries developed spontaneous myogenic tone equivalent to 1.3 ± 0.1 mN (≈ 15% of maximum tension, with 55 mmol/L KCl, n = 40) with a resting membrane potential (E<sub>m</sub>) of −42.1 ± 0.9 mV (n = 40). Addition of the NOS inhibitor, L-NAME (100 μM), and the cyclooxygenase inhibitor, indomethacin (10 μM) tended to evoke smooth muscle cell depolarization (E<sub>m</sub> −39.2 ± 1.0 mV, n = 38) and constriction (4.6 ± 0.2 mN, n = 40; <italic>P</italic> &lt; 0.05). In all vessels, the depolarization developed into ongoing oscillations (amplitude 7 ± 0.9 mV) followed by equivalent changes in tone (amplitude 0.12 ± 0.01 mN). We have previously reported similar observations in the rat middle cerebral artery following NOS inhibition alone (<xref rid="bib67" ref-type="bibr">Yuill et al., 2010</xref>). With L-NAME present, stimulation of the endothelium with 20 μM SLIGRL evoked hyperpolarization of 20.9 ± 1.7 mV (n = 31) associated with 77.6 ± 3.6% relaxation (n = 37).</p>
        <p>In the presence of L-NAME and indomethacin, the BK<sub>Ca</sub> channel inhibitor, iberiotoxin (100 nM), evoked further depolarization (to E<sub>m</sub> −35.7 ± 1.1 mV, n = 40; <italic>P</italic> &lt; 0.05) and constriction (to 5.7 ± 0.2 mN, n = 41; <italic>P</italic> &lt; 0.05), associated with a marked increase in the amplitude of oscillations in E<sub>m</sub> temporally linked to tension (<xref rid="fig1" ref-type="fig">Fig. 1</xref>B). The oscillations in E<sub>m</sub> and tension had a frequency of 0.84 ± 0.02 Hz and 0.80 ± 0.05 Hz and amplitude of 22.6 ± 1.3 mV and 0.19 ± 0.02 mN, respectively (n = 41). All subsequent experiments were performed in the presence of L-NAME, indomethacin and iberiotoxin unless stated. Removal of the endothelium abolished SLIGRL-mediated relaxation (20 μM), but failed to affect oscillations in E<sub>m</sub> (frequency of 0.76 ± 0.10 Hz; amplitude of 19.4 ± 4.3 mV) and tension (frequency of 0.66 ± 0.10 Hz; amplitude of 0.16 ± 0.05 mN, n = 3).</p>
      </sec>
      <sec>
        <label>3.2</label>
        <title>[Ca<sup>2+</sup>]<sub>o</sub> but not Na<sup>+</sup> or Cl<sup>−</sup> currents modify oscillations in membrane potential</title>
        <p>The voltage-dependent Na<sup>+</sup> channel blocker, tetrodotoxin (1 μM) did not modify either the frequency or amplitude of oscillations in E<sub>m</sub> (control: frequency of 0.84 ± 0.03 Hz, amplitude of 16.1 ± 1.4 mV; tetrodotoxin: frequency of 0.90 ± 0.02 Hz, amplitude of 15.4 ± 2.7 mV, n = 3) and tension (control: frequency of 0.73 ± 0.11 Hz, amplitude of 0.13 ± 0.01 mN; tetrodotoxin: frequency of 0.67 ± 0.14 Hz, amplitude of 0.12 ± 0.01 mN, n = 3).</p>
        <p>To investigate if the oscillations were dependent upon Ca<sup>2+</sup> influx, we decreased extracellular Ca<sup>2+</sup> in steps from 2.5 to 0 mM. Simultaneous measurements of changes in E<sub>m</sub> and tension showed that decreasing Ca<sup>2+</sup> evoked depolarization (from −37.0 ± 2.1 to −26.8 ± 2.4 mV, n = 7; <italic>P</italic> &lt; 0.05) and relaxation (from 5.4 ± 0.6 to 0.3 ± 0.1 mN, n = 7; <italic>P</italic> &lt; 0.05). Under these conditions, the amplitude of oscillations in E<sub>m</sub> and tension was diminished (<xref rid="fig1" ref-type="fig">Fig. 1</xref>C and D). The calcium-dependent Cl<sup>−</sup> channel inhibitor, DIDS (150 μM), did not alter spontaneous oscillations in E<sub>m</sub> or tension (data not shown) nor did it modify E<sub>m</sub> (control: −44.4 ± 3.0 mV; DIDS: −49.2 ± 3.9 mV, n = 5) or tension (control: 4.7 ± 0.6 mN; DIDS: 3.6 ± 0.5 mN, n = 5).</p>
      </sec>
      <sec>
        <label>3.3</label>
        <title>Effect of Ca<sup>2+</sup>channel blockers on oscillations in E<sub>m</sub> and tension</title>
        <p>The T-type selective Ca<sup>2+</sup> channel blocker, mibefradil (100 nM) abolished oscillations in E<sub>m</sub> (<xref rid="fig2" ref-type="fig">Fig. 2</xref>A), significantly reduced oscillations in tension (control: frequency of 0.79 ± 0.07 Hz, amplitude of 0.16 ± 0.04 mN; mibefradil: frequency of 0.09 ± 0.05 Hz, amplitude of 0.04 ± 0.02 mN, n = 5; <italic>P</italic> &lt; 0.05) and evoked relaxation (control: 5.1 ± 0.7 mN; mibefradil: 3.5 ± 0.6 mN, n = 5) and depolarization (E<sub>m</sub> control: −36.1 ± 1.3 mV; E<sub>m</sub> mibefradil: −30.4 ± 2.5 mV, n = 5). The more selective T-type Ca<sup>2+</sup> channel antagonist, NNC 55-0396 (300 nM) also significantly reduced oscillations in E<sub>m</sub> (<xref rid="fig2" ref-type="fig">Fig. 2</xref>B) and in tension (control: frequency of 0.79 ± 0.09 Hz, amplitude of 0.17 ± 0.03 mN; NNC 55-0396: frequency of 0.20 ± 0.07 Hz, amplitude of 0.07 ± 0.02 mN, n = 6; <italic>P</italic> &lt; 0.05) and evoked relaxation (control: 5.5 ± 0.5 mN; NNC 55-0396: 3.0 ± 0.5 mN, n = 6; <italic>P</italic> &lt; 0.05). However, NNC 55-0396 did not significantly modify mean E<sub>m</sub> (E<sub>m</sub> control: −36.2 ± 3.2 mV; E<sub>m</sub> NNC 55-0396: −31.9 ± 3.2 mV, n = 6). Further addition of the L-type voltage-gated Ca<sup>2+</sup> channel inhibitor, nifedipine (1 μM), relaxed (control: 5.8 ± 0.7 mN; NNC 55-0396 3.5 ± 0.6 mN; NNC 55-0396 + nifedipine: 0.5 ± 0.1 mN, n = 4; <italic>P</italic> &lt; 0.05) and hyperpolarized (E<sub>m</sub> control: −33.0 ± 3.7 mV; E<sub>m</sub> NNC 55-0396: −30.0 ± 4.6; Em NNC 55-0396 + nifedipine: −36.7 ± 3.4 mV, n = 4; <xref rid="fig2" ref-type="fig">Fig. 2</xref>C). We also assessed the effect of NNC 55-0396 against middle cerebral artery basal myogenic tone in the absence of inhibitors. NNC 55-0396 (300 nM) did not significantly affect E<sub>m</sub> (E<sub>m</sub> control: −51.6 ± 2.47; E<sub>m</sub> NNC 55-0396: −48.9 ± 2.0 mV, n = 5) or relax myogenic tone (control: 1.04 ± 0.18; NNC 55-0396: 0.69 ± 0.09 mN) under these conditions. The additional presence of nifedipine (1 μM) also failed to evoke hyperpolarization (E<sub>m</sub> NNC 55-0396+ nifedipine: −51.5 ± 2.8 mV) but did cause significant relaxation (NNC 55-0396+ nifedipine: 0.44 ± 0.04 mN, n = 4, P &lt; 0.05). We have previously demonstrated similar relaxation of basal myogenic tone with nifedipine alone (<xref rid="bib67" ref-type="bibr">Yuill et al., 2010</xref>).</p>
      </sec>
      <sec>
        <label>3.4</label>
        <title>Involvement of K<sub>Ca</sub>3.1(IK<sub>Ca</sub>) and K<sub>Ca</sub>2.3(SK<sub>Ca</sub>) channels</title>
        <p>Addition of the K<sub>Ca</sub>3.1 channel blocker, TRAM-34 (1 μM) markedly decreased the amplitude of oscillations in E<sub>m</sub> and tension (<xref rid="fig3" ref-type="fig">Fig. 3</xref>B) followed by small relaxation (control: 6.5 ± 0.4 mN; TRAM-34: 5.3 ± 0.2 mN, n = 5; <italic>P</italic> &lt; 0.05). TRAM-34 did not significantly reduce E<sub>m</sub>, (E<sub>m</sub> control: −33.9 ± 2.6 mV; E<sub>m</sub> TRAM-34: −28.7 ± 2.3 mV, n = 4). The effect of TRAM-34 on the amplitude of oscillations in E<sub>m</sub> (control: 19.4 ± 4.3 mV; TRAM-34: 3.0 ± 1.6 mV, n = 3; <italic>P</italic> &lt; 0.05) and tension (control: 0.16 ± 0.05 mN; TRAM-34: 0.04 ± 0.02 mN, n = 3) was similar after endothelium removal. The oscillations in E<sub>m</sub> and tension were not modified by the K<sub>Ca</sub>2.3 blocker apamin (50 nM), either alone (<xref rid="fig3" ref-type="fig">Fig. 3</xref>C) or in the additional presence of TRAM-34 (<xref rid="fig3" ref-type="fig">Fig. 3</xref>D). Likewise, charybdotoxin (100 nM) alone (<xref rid="fig4" ref-type="fig">Fig. 4</xref>B) or with apamin (<xref rid="fig4" ref-type="fig">Fig. 4</xref>C) did not affect either oscillations in E<sub>m</sub> and tension (<xref rid="fig4" ref-type="fig">Fig. 4</xref>D and E), or mean tension and E<sub>m</sub>.</p>
      </sec>
      <sec>
        <label>3.5</label>
        <title>Involvement of K<sub>IR</sub> channels, voltage-gated K<sup>+</sup> channels and the Na<sup>+</sup>/K<sup>+</sup>-ATPase</title>
        <p>Inhibition of K<sub>IR</sub> channels with BaCl<sub>2</sub> (30 μM) did not affect the amplitude of oscillations in E<sub>m</sub> (control: 31.1 ± 4.6 mV; BaCl<sub>2</sub>: 30.9 ± 6.1 mV, n = 5) or tension (control: 0.20 ± 0.03 mN; Ba<sup>2+</sup>: 0.19 ± 0.03 mV, n = 5). However, another inhibitor of K<sub>IR</sub>, CsCl (10 mM) increased the amplitude of oscillations in E<sub>m</sub> (control: 30.8 ± 2.0 mV; CsCl: 40.4 ± 3.4 mV, n = 5; <italic>P</italic> &lt; 0.05), but not in tension (control: 0.20 ± 0.02 mN; CsCl: 0.19 ± 0.02 mV, n = 5), while 4-aminopyridine (4-AP; 3 mM to block K<sub>v</sub>) increased the amplitude of oscillations in both E<sub>m</sub> (control: 17.75 ± 2.07; 4-AP: 30.62 ± 7.33 mV, n = 3) and tension (control: 0.17 ± 0.01; 4-AP: 0.25 ± 0.07 mN; n = 3, <xref rid="fig5" ref-type="fig">Fig. 5</xref>A). The Na<sup>+</sup>/K<sup>+</sup>-ATPase inhibitor, ouabain (1 μM) evoked relaxation (control: 5.8 ± 0.3 mN; ouabain: 4.6 ± 0.2 mN, n = 3; <italic>P</italic> &lt; 0.05) but without significantly reducing E<sub>m</sub> (control: −42.2 ± 1.2 mV; ouabain: −38.4 ± 1.6 mV, n = 3). However, ouabain did reduce both the amplitude (<xref rid="fig5" ref-type="fig">Fig. 5</xref>B and C) and frequency (control: 0.97 ± 0.11 Hz; ouabain: 0.31 ± 0.16 Hz, n = 3; <italic>P</italic> &lt; 0.05) of oscillations in E<sub>m</sub>, without altering oscillations in tension (<xref rid="fig5" ref-type="fig">Fig. 5</xref>C and frequency control: 1.30 ± 0.22 Hz; plus ouabain: 0.92 ± 0.22 Hz, n = 3). The subsequent addition of 4-AP in the presence of ouabain caused depolarization (ouabain: −38.4 ± 1.6 mV; ouabain +4-AP: −34.6 ± 3.3 mV, n = 3; P &lt; 0.05), and increased oscillations in Em (<xref rid="fig5" ref-type="fig">Fig. 5</xref>C) and increased tension overall (ouabain: 4.6 ± 0.2 mN; ouabain + 4-AP: 5.5 ± 0.2 mN, n = 3; P &lt; 0.05).</p>
      </sec>
    </sec>
    <sec>
      <label>4</label>
      <title>Discussion</title>
      <p>This study provides the first demonstration, that rhythmic oscillations in membrane potential and tension as well as the associated spasm in rat isolated middle cerebral arteries following inhibition of BK<sub>Ca</sub> channels and/or NOS reflect Ca<sup>2+</sup> influx via T-type Ca<sup>2+</sup> channels, in addition to L-type Ca<sup>2+</sup> channels. These data extend our previous observation that NOS inhibition leads to L-type Ca<sup>2+</sup> channel opening and arterial spasm, characterized by sustained constriction and superimposed by rapid vasomotion (<xref rid="bib67" ref-type="bibr">Yuill et al., 2010</xref>). Vasomotion was of much higher frequency than previously recorded in other vascular beds, and as such we refer to it as ‘vasospastic’ vasomotion. We also provide evidence for modulation of both the Ca<sup>2+</sup> dependent vasomotion and constriction through Na/K ATPase and a K<sup>+</sup> conductance.</p>
      <p>Consistent with previous work, our data suggest that calcium influx underlies rhythmic oscillations in the constricted rat middle cerebral artery, and that oscillations in membrane potential and tension are linked to oscillations in intracellular [Ca<sup>2+</sup>]<sub>i</sub> as well as spasm in both middle cerebral and basilar arteries (<xref rid="bib19 bib50 bib67" ref-type="bibr">Haddock and Hill, 2002; Navarro-Gonzalez et al., 2009; Yuill et al., 2010</xref>). Reducing extracellular calcium diminished the amplitude of oscillations, led to relaxation and paradoxically depolarized the membrane. The relaxation presumably reflected the reduction in peak E<sub>m</sub> associated with the reduced amplitude of oscillations in E<sub>m</sub>. Some small oscillations in tension did persist and may reflect vasomotion-independent intracellular calcium release, as reported in some arterial beds: for review see <xref rid="bib20" ref-type="bibr">Haddock and Hill (2005)</xref>. As oscillations were insensitive to the calcium-dependent Cl<sup>−</sup> channel inhibitor, DIDS and the voltage-dependent Na<sup>+</sup> channel blocking agent, tetrodotoxin they certainly appeared to be mediated exclusively by calcium conductance. These data contrast with the basilar artery, where inhibition of Cl<sup>−</sup> channels in this larger artery abolished calcium-dependent oscillations, leading to hyperpolarization and relaxation (<xref rid="bib19" ref-type="bibr">Haddock and Hill, 2002</xref>) and parenchymal arterioles, where calcium-dependent oscillations were blocked with tetrodotoxin (<xref rid="bib11" ref-type="bibr">Filosa et al., 2004</xref>). However, our data are consistent with human pial arteries, where tetrodotoxin was also without effect against oscillations in diameter (<xref rid="bib13" ref-type="bibr">Gokina et al., 1996</xref>). In the present study, oscillations in muscle membrane potential were also resistant to direct damage of the endothelium, suggesting that this monolayer may not influence rapid vasomotion associated with arterial spasm.</p>
      <p>In the rat middle cerebral artery, opening L-type Ca<sup>2+</sup> channels is essential for vasoconstriction and vasomotion to develop, because inhibition of these channels abolishes vasomotion and fully reverses tone (<xref rid="bib67" ref-type="bibr">Yuill et al., 2010</xref>). Surprisingly, in the present study under similar vasospastic conditions, oscillations in E<sub>m</sub>, and the associated oscillations in tension were abolished and followed by relaxation after calcium influx through T-type Ca<sup>2+</sup> channels was blocked with mibefradil (at a concentration selective for block of T-type Ca<sup>2+</sup> channels; 100 nM) or with a T-type Ca<sup>2+</sup> channel selective, non-hydrolysable analogue of mibefradil, NNC 55-0396, (<xref rid="bib24" ref-type="bibr">Huang et al., 2004</xref>). Block of oscillations with the putative T-type Ca<sup>2+</sup> channel blockers was not associated with a net hyperpolarization and complete relaxation, contrasting with the L-Type Ca<sup>2+</sup> channel blocker nifedipine. So the effect of mibefradil or NNC 55-0396 is unlikely to reflect a non-specific effect against L-type channels. Furthermore, although mibefradil apparently reduced blood pressure and myogenic tone by an action on L-type calcium channels (<xref rid="bib46" ref-type="bibr">Moosmang et al., 2006</xref>), the lower concentration of mibefradil used in the present study is relatively specific against T-type Ca<sup>2+</sup> channels. In fact, mibefradil seems only to inhibit the L-type Ca<sup>2+</sup> channels after tissue metabolism (<xref rid="bib65" ref-type="bibr">Wu et al., 2000</xref>). The non-hydrolysable analogue of mibefradil NNC 55-0396 is selective for T-type Ca<sup>2+</sup> channels, with no reported block of L-type Ca<sup>2+</sup> channels even in concentrations as high as 100 μM (<xref rid="bib24" ref-type="bibr">Huang et al., 2004</xref>). Mibefradil has also been reported to block both Cl<sup>−</sup> (<xref rid="bib2" ref-type="bibr">Bernd et al., 1997</xref>) and Na<sup>+</sup> (<xref rid="bib10 bib15" ref-type="bibr">Eller et al., 2000; Guatimosim et al., 2001</xref>) channels, but again with much higher concentrations (μM) than employed in the current study. Furthermore, the fact that blockers such as DIDs and TTX had no effect against vasospastic vasomotion makes an action of mibefradil against these channels extremely unlikely. Therefore, the differential effect of mibefradil and NNC-0396 compared to the selective blocker L-type Ca<sup>2+</sup> channel blocker nifedipine indicates a critical role for T-type Ca<sup>2+</sup> channels in vasospastic vasomotion. Further, these channels contribute significantly to the overall constriction in the middle cerebral artery.</p>
      <p>Vasospastic vasomotion only developed once the smooth muscle cells depolarized to <italic>circa</italic> −40 mV, so it may be that T-type channels involved in vasomotion have gating properties similar to high voltage activated Ca<sup>2+</sup> channels. This is surprising, as by definition T-type Ca<sup>2+</sup> channels activate at low potentials and then quickly inactivate (<xref rid="bib35" ref-type="bibr">Lacinova, 2005</xref>). However, our data are consistent with studies reporting T-type Ca<sup>2+</sup> channels that influence vascular tone and have properties similar to high voltage activated Ca<sup>2+</sup> channels, (<xref rid="bib50" ref-type="bibr">Navarro-Gonzalez et al., 2009</xref>). Both T- and L-type Ca<sup>2+</sup> channels are expressed in rat basilar (<xref rid="bib50" ref-type="bibr">Navarro-Gonzalez et al., 2009</xref>) and middle cerebral arteries (<xref rid="bib34" ref-type="bibr">Kuo et al., 2008</xref>), and in each artery the CaV<sub>3.2</sub> (or T-type) is the most abundant VGCC alpha subunit expressed. Human recombinant T-type Ca<sup>2+</sup> channels (<xref rid="bib29" ref-type="bibr">Kaku et al., 2003</xref>) and T-type Ca<sup>2+</sup> channels co-expressed with auxiliary subunits (<xref rid="bib66" ref-type="bibr">Wyatt et al., 1998</xref>) do have gating properties similar to high voltage activated channels, so channels in the middle cerebral artery may be similar. Peripheral arteries also contain VGCCs with similar biophysical properties to high voltage activated channels (−50 to −20 mV), and are pharmacologically indistinguishable from T-type Ca<sup>2+</sup> channels in both the guinea-pig and rat (<xref rid="bib48 bib49" ref-type="bibr">Morita et al., 1999; Morita et al., 2002</xref>). In these small mesenteric arteries, T-type Ca<sup>2+</sup> channels are the predominant voltage-gated subtype (<xref rid="bib16 bib27" ref-type="bibr">Gustafsson et al., 2001; Jensen et al., 2004</xref>), and show increased window current due to non-inactivation at physiological E<sub>m</sub> (<xref rid="bib26" ref-type="bibr">Jensen and Holstein-Rathlou, 2009</xref>).</p>
      <p>As nifedipine abolished vasomotion, we propose that L-type channels are key for the initial depolarization and constriction (<xref rid="bib67" ref-type="bibr">Yuill et al., 2010</xref>); whereas T-type are activated subsequently and as such is critical for the vasospastic vasomotion. Interestingly, input from T-type Ca<sup>2+</sup> channels seems to be important for the initial constriction in the basilar artery, whereas L-type channels are critical for vasomotion (<xref rid="bib50" ref-type="bibr">Navarro-Gonzalez et al., 2009</xref>). But taken together, these results all suggest a functional coupling between L- and T-type Ca<sup>2+</sup> channels, as previously suggested in renal (<xref rid="bib21" ref-type="bibr">Hansen et al., 2001</xref>) and mesenteric arterioles (<xref rid="bib4" ref-type="bibr">Braunstein et al., 2008</xref>). As such, this might explain why neuroprotection in ischemic stroke is more effective in patients given blockers for more than just L-type VGCCs (<xref rid="bib32" ref-type="bibr">Kobayashi and Mori, 1998</xref>).</p>
      <p>As VGCC and hence vasospastic vasomotion are inhibited by a complex interaction between NO and smooth muscle cell BK<sub>Ca</sub> channels in middle cerebral arteries, we attempted to characterize further the vasospastic vasomotion. Endothelial cell damage did not affect the vasomotion, so we inhibited a variety of K<sup>+</sup> currents. Both inwardly rectifying and voltage-gated K<sup>+</sup> channels participate in maintenance of resting membrane potential and vascular tone (<xref rid="bib31 bib52 bib60" ref-type="bibr">Ko et al., 2008; Nelson and Quayle, 1995 Sobey, 2001</xref>). However, inhibition of K<sub>IR</sub> channels with CsCl or barium did not affect vascular tone, although CsCl did slightly increase E<sub>m</sub> oscillation amplitude. As Ba<sup>2+</sup> was without effect, this small change most likely reflected a non-selective action of CsCl. Inhibition of K<sub>v</sub> channels with 4-AP also had little effect, causing only a small increase in the amplitude of oscillations in E<sub>m</sub> and tension. This is consistent with the reported role of these channels in rat mesenteric artery where inhibition of K<sub>v</sub> increased rhythmic contractions (<xref rid="bib18" ref-type="bibr">Gustafsson and Nilsson, 1994</xref>). So voltage-gated K<sup>+</sup> channels did not appear to play any major role in vasospastic vasomotion.</p>
      <p>Our data do suggest that Na<sup>+</sup>/K<sup>+</sup>-ATPase might contribute to vasomotion, as ouabain caused relaxation and reduced the amplitude and frequency of oscillations in E<sub>m</sub>, although surprisingly without affecting oscillations in tension. Ouabain can attenuate intercellular communication in smooth muscle (<xref rid="bib22 bib39 bib41" ref-type="bibr">Harris et al., 2000; Martin et al., 2003; Matchkov et al., 2007</xref>) and the synchronized changes in vascular [Ca<sup>2+</sup>]<sub>i</sub> (<xref rid="bib33" ref-type="bibr">Koenigsberger et al., 2004</xref>) that lead to vasomotion (<xref rid="bib6 bib42 bib54" ref-type="bibr">Chaytor et al., 1997; Matchkov et al., 2004; Peng et al., 2001</xref>). So in part, ouabain may alter membrane potential oscillations by modifying cell–cell communication. Interestingly, ouabain effects were reversed by 4-AP, again indicating that K<sub>V</sub> might contribute under some conditions to influence vasomotion.</p>
      <p>The ability of the K<sub>Ca</sub>3.1 channel inhibitor TRAM-34 to reduce rather than enhance the amplitude of oscillations in E<sub>m</sub> and tension was also unexpected. This effect was on the smooth muscle, as it was not altered by removal of the endothelium, and in contrast to TRAM-34, charybdotoxin, a mixed BK<sub>Ca</sub> and K<sub>Ca</sub>3.1 inhibitor failed to modify the oscillations. One explanation is that TRAM-34 inhibits non-selective cation channels in the smooth muscle, similar to its action in isolated immune cells (<xref rid="bib57" ref-type="bibr">Schilling and Eder, 2007</xref>). Non-selective cation channels are present in rat middle cerebral artery smooth muscle cells and appear to contribute to the calcium entry and vascular tone (<xref rid="bib38 bib64" ref-type="bibr">Marrelli et al., 2007; Welsh et al., 2002</xref>). So data with TRAM-34 suggest that non-selective cation channels may play an important role in the calcium entry events underpinning depolarization and vasomotion after NOS inhibition in the middle cerebral artery.</p>
      <p>In summary, inhibition of either BK<sub>Ca</sub> channels and/or NOS evokes vasospasm and fast, rhythmic oscillations in E<sub>m</sub> and tension that are mediated by Ca<sup>2+</sup> influx via both T-type and L-type Ca<sup>2+</sup> channels. Our data suggest that the T-type channels are active at physiologically relevant membrane potentials and can therefore make an important contribution to the control of cerebrovascular blood flow during vasospasm associated with disease states where NO synthesis or action is impaired, such as cerebral ischemia or subarachnoid haemorrhage.</p>
    </sec>
  </body>
  <back>
    <ref-list>
      <title>References</title>
      <ref id="bib1">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Alexander</surname>
              <given-names>S.P.H.</given-names>
            </name>
            <name>
              <surname>Mathie</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Peters</surname>
              <given-names>J.A.</given-names>
            </name>
          </person-group>
          <article-title>Guide to Receptors and Channels (GRAC), 3rd edition</article-title>
          <source>Brit J Pharmacol</source>
          <volume>153</volume>
          <issue>S2</issue>
          <year>2008</year>
          <fpage>S1</fpage>
          <pub-id pub-id-type="pmid">18347570</pub-id>
        </element-citation>
      </ref>
      <ref id="bib2">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bernd</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Jean</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Masahiro</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Felix</surname>
              <given-names>V.</given-names>
            </name>
            <name>
              <surname>Thomas</surname>
              <given-names>V.</given-names>
            </name>
            <name>
              <surname>Guy</surname>
              <given-names>D.</given-names>
            </name>
          </person-group>
          <article-title>Inhibition by mibefradil, a novel calcium channel antagonist, of Ca2+- and volume-activated Cl<sup>−</sup> channels in macrovascular endothelial cells</article-title>
          <source>Brit Jl Pharmacol</source>
          <volume>121</volume>
          <issue>3</issue>
          <year>1997</year>
          <fpage>547</fpage>
          <lpage>555</lpage>
        </element-citation>
      </ref>
      <ref id="bib3">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Biswal</surname>
              <given-names>B.B.</given-names>
            </name>
            <name>
              <surname>Hudetz</surname>
              <given-names>A.G.</given-names>
            </name>
          </person-group>
          <article-title>Synchronous oscillations in cerebrocortical capillary red blood cell velocity after nitric oxide synthase inhibition</article-title>
          <source>Microvasc. Res.</source>
          <volume>52</volume>
          <issue>1</issue>
          <year>1996</year>
          <fpage>1</fpage>
          <lpage>12</lpage>
          <pub-id pub-id-type="pmid">8812747</pub-id>
        </element-citation>
      </ref>
      <ref id="bib4">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Braunstein</surname>
              <given-names>T.H.</given-names>
            </name>
            <name>
              <surname>Inoue</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Cribbs</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Oike</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Ito</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Holstein-Rathlou</surname>
              <given-names>N.H.</given-names>
            </name>
            <name>
              <surname>Jensen</surname>
              <given-names>L.J.</given-names>
            </name>
          </person-group>
          <article-title>The role of L- and T-type calcium channels in local and remote calcium responses in rat mesenteric terminal arterioles</article-title>
          <source>J. Vasc. Res.</source>
          <volume>46</volume>
          <issue>2</issue>
          <year>2008</year>
          <fpage>138</fpage>
          <lpage>151</lpage>
          <pub-id pub-id-type="pmid">18765948</pub-id>
        </element-citation>
      </ref>
      <ref id="bib5">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Brayden</surname>
              <given-names>J.E.</given-names>
            </name>
            <name>
              <surname>Nelson</surname>
              <given-names>M.T.</given-names>
            </name>
          </person-group>
          <article-title>Regulation of arterial tone by activation of calcium-dependent potassium channels</article-title>
          <source>Science</source>
          <volume>256</volume>
          <issue>5056</issue>
          <year>1992</year>
          <fpage>532</fpage>
          <lpage>535</lpage>
          <pub-id pub-id-type="pmid">1373909</pub-id>
        </element-citation>
      </ref>
      <ref id="bib6">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chaytor</surname>
              <given-names>A.T.</given-names>
            </name>
            <name>
              <surname>Evans</surname>
              <given-names>W.H.</given-names>
            </name>
            <name>
              <surname>Griffith</surname>
              <given-names>T.M.</given-names>
            </name>
          </person-group>
          <article-title>Peptides homologous to extracellular loop motifs of connexin 43 reversibly abolish rhythmic contractile activity in rabbit arteries</article-title>
          <source>J. Physiol.</source>
          <volume>503</volume>
          <issue>Pt 1</issue>
          <year>1997</year>
          <fpage>99</fpage>
          <lpage>110</lpage>
          <pub-id pub-id-type="pmid">9288678</pub-id>
        </element-citation>
      </ref>
      <ref id="bib7">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Clozel</surname>
              <given-names>J.P.</given-names>
            </name>
            <name>
              <surname>Ertel</surname>
              <given-names>E.A.</given-names>
            </name>
            <name>
              <surname>Ertel</surname>
              <given-names>S.I.</given-names>
            </name>
          </person-group>
          <article-title>Discovery and main pharmacological properties of mibefradil (Ro 40-5967), the first selective T-type calcium channel blocker</article-title>
          <source>J. Hypertens. Suppl.</source>
          <volume>15</volume>
          <issue>5</issue>
          <year>1997</year>
          <fpage>S17</fpage>
          <lpage>S25</lpage>
          <pub-id pub-id-type="pmid">9481612</pub-id>
        </element-citation>
      </ref>
      <ref id="bib8">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Davis</surname>
              <given-names>M.J.</given-names>
            </name>
            <name>
              <surname>Hill</surname>
              <given-names>M.A.</given-names>
            </name>
          </person-group>
          <article-title>Signaling mechanisms underlying the vascular myogenic response</article-title>
          <source>Physiol. Rev.</source>
          <volume>79</volume>
          <issue>2</issue>
          <year>1999</year>
          <fpage>387</fpage>
          <lpage>423</lpage>
          <pub-id pub-id-type="pmid">10221985</pub-id>
        </element-citation>
      </ref>
      <ref id="bib9">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dirnagl</surname>
              <given-names>U.</given-names>
            </name>
            <name>
              <surname>Lindauer</surname>
              <given-names>U.</given-names>
            </name>
            <name>
              <surname>Villringer</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>Nitric oxide synthase blockade enhances vasomotion in the cerebral microcirculation of anesthetized rats</article-title>
          <source>Microvasc. Res.</source>
          <volume>45</volume>
          <issue>3</issue>
          <year>1993</year>
          <fpage>318</fpage>
          <lpage>323</lpage>
          <pub-id pub-id-type="pmid">7686608</pub-id>
        </element-citation>
      </ref>
      <ref id="bib10">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Eller</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Berjukov</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Wanner</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Huber</surname>
              <given-names>I.</given-names>
            </name>
            <name>
              <surname>Hering</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Knaus</surname>
              <given-names>H.-G.</given-names>
            </name>
            <name>
              <surname>Toth</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Kimball</surname>
              <given-names>S.D.</given-names>
            </name>
            <name>
              <surname>Striessnig</surname>
              <given-names>J.</given-names>
            </name>
          </person-group>
          <article-title>High affinity interaction of mibefradil with voltage-gated calcium and sodium channels</article-title>
          <source>Brit J of Pharmacol</source>
          <volume>130</volume>
          <issue>3</issue>
          <year>2000</year>
          <fpage>669</fpage>
          <lpage>677</lpage>
          <pub-id pub-id-type="pmid">10821797</pub-id>
        </element-citation>
      </ref>
      <ref id="bib11">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Filosa</surname>
              <given-names>J.A.</given-names>
            </name>
            <name>
              <surname>Bonev</surname>
              <given-names>A.D.</given-names>
            </name>
            <name>
              <surname>Nelson</surname>
              <given-names>M.T.</given-names>
            </name>
          </person-group>
          <article-title>Calcium dynamics in cortical astrocytes and arterioles during neurovascular coupling</article-title>
          <source>Circ. Res.</source>
          <volume>95</volume>
          <issue>10</issue>
          <year>2004</year>
          <fpage>e73</fpage>
          <lpage>e81</lpage>
          <pub-id pub-id-type="pmid">15499024</pub-id>
        </element-citation>
      </ref>
      <ref id="bib12">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Garland</surname>
              <given-names>C.J.</given-names>
            </name>
            <name>
              <surname>McPherson</surname>
              <given-names>G.A.</given-names>
            </name>
          </person-group>
          <article-title>Evidence that nitric oxide does not mediate the hyperpolarisation and relaxation to acetylcholine in the rat small mesenteric artery</article-title>
          <source>Br. J. Pharmacol.</source>
          <volume>105</volume>
          <year>1992</year>
          <fpage>429</fpage>
          <lpage>435</lpage>
          <pub-id pub-id-type="pmid">1559132</pub-id>
        </element-citation>
      </ref>
      <ref id="bib13">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gokina</surname>
              <given-names>N.I.</given-names>
            </name>
            <name>
              <surname>Bevan</surname>
              <given-names>R.D.</given-names>
            </name>
            <name>
              <surname>Walters</surname>
              <given-names>C.L.</given-names>
            </name>
            <name>
              <surname>Bevan</surname>
              <given-names>J.A.</given-names>
            </name>
          </person-group>
          <article-title>Electrical activity underlying rhythmic contraction in human pial arteries</article-title>
          <source>Circ. Res.</source>
          <volume>78</volume>
          <issue>1</issue>
          <year>1996</year>
          <fpage>148</fpage>
          <lpage>153</lpage>
          <pub-id pub-id-type="pmid">8603497</pub-id>
        </element-citation>
      </ref>
      <ref id="bib14">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Golding</surname>
              <given-names>E.M.</given-names>
            </name>
            <name>
              <surname>Steenberg</surname>
              <given-names>M.L.</given-names>
            </name>
            <name>
              <surname>Johnson</surname>
              <given-names>T.D.</given-names>
            </name>
            <name>
              <surname>Bryan</surname>
              <given-names>R.M.</given-names>
            </name>
          </person-group>
          <article-title>Nitric oxide in the potassium-induced response of the rat middle cerebral artery: a possible permissive role</article-title>
          <source>Brain Res.</source>
          <volume>889</volume>
          <issue>1–2</issue>
          <year>2001</year>
          <fpage>98</fpage>
          <lpage>104</lpage>
          <pub-id pub-id-type="pmid">11166692</pub-id>
        </element-citation>
      </ref>
      <ref id="bib15">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Guatimosim</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Sobie</surname>
              <given-names>E.A.</given-names>
            </name>
            <name>
              <surname>dos Santos Cruz</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Martin</surname>
              <given-names>L.A.</given-names>
            </name>
            <name>
              <surname>Lederer</surname>
              <given-names>W.J.</given-names>
            </name>
          </person-group>
          <article-title>Molecular identification of a TTX-sensitive Ca<sup>2+</sup> current</article-title>
          <source>Am. J. Physiol. Cell Physiol.</source>
          <volume>280</volume>
          <issue>5</issue>
          <year>2001</year>
          <fpage>C1327</fpage>
          <lpage>C1339</lpage>
          <pub-id pub-id-type="pmid">11287346</pub-id>
        </element-citation>
      </ref>
      <ref id="bib16">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gustafsson</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Andreasen</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Salomonsson</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Jensen</surname>
              <given-names>B.L.</given-names>
            </name>
            <name>
              <surname>Holstein-Rathlou</surname>
              <given-names>N.</given-names>
            </name>
          </person-group>
          <article-title>Conducted vasoconstriction in rat mesenteric arterioles: role for dihydropyridine-insensitive Ca(2+) channels</article-title>
          <source>Am. J. Physiol. Heart Circ. Physiol.</source>
          <volume>280</volume>
          <issue>2</issue>
          <year>2001</year>
          <fpage>H582</fpage>
          <lpage>H590</lpage>
          <pub-id pub-id-type="pmid">11158955</pub-id>
        </element-citation>
      </ref>
      <ref id="bib17">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gustafsson</surname>
              <given-names>H.</given-names>
            </name>
          </person-group>
          <article-title>Vasomotion and underlying mechanisms in small arteries</article-title>
          <source>An in vitro study of rat blood vessels. Acta Physiol Scand Suppl</source>
          <volume>614</volume>
          <year>1993</year>
          <fpage>1</fpage>
          <lpage>44</lpage>
        </element-citation>
      </ref>
      <ref id="bib18">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gustafsson</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Nilsson</surname>
              <given-names>H.</given-names>
            </name>
          </person-group>
          <article-title>Rhythmic contractions in isolated small arteries of rat: role of K<sup>+</sup> channels and the Na<sup>+</sup>, K(<sup>+</sup>)-pump</article-title>
          <source>Acta Physiol. Scand.</source>
          <volume>150</volume>
          <issue>2</issue>
          <year>1994</year>
          <fpage>161</fpage>
          <lpage>170</lpage>
          <pub-id pub-id-type="pmid">8191895</pub-id>
        </element-citation>
      </ref>
      <ref id="bib19">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Haddock</surname>
              <given-names>R.E.</given-names>
            </name>
            <name>
              <surname>Hill</surname>
              <given-names>C.E.</given-names>
            </name>
          </person-group>
          <article-title>Differential activation of ion channels by inositol 1, 4, 5-trisphosphate (IP3)- and ryanodine-sensitive calcium stores in rat basilar artery vasomotion</article-title>
          <source>J. Physiol.</source>
          <volume>545</volume>
          <issue>Pt 2</issue>
          <year>2002</year>
          <fpage>615</fpage>
          <lpage>627</lpage>
          <pub-id pub-id-type="pmid">12456838</pub-id>
        </element-citation>
      </ref>
      <ref id="bib20">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Haddock</surname>
              <given-names>R.E.</given-names>
            </name>
            <name>
              <surname>Hill</surname>
              <given-names>C.E.</given-names>
            </name>
          </person-group>
          <article-title>Rhythmicity in arterial smooth muscle</article-title>
          <source>J. Physiol.</source>
          <volume>566</volume>
          <issue>Pt 3</issue>
          <year>2005</year>
          <fpage>645</fpage>
          <lpage>656</lpage>
          <pub-id pub-id-type="pmid">15905215</pub-id>
        </element-citation>
      </ref>
      <ref id="bib21">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hansen</surname>
              <given-names>P.B.</given-names>
            </name>
            <name>
              <surname>Jensen</surname>
              <given-names>B.L.</given-names>
            </name>
            <name>
              <surname>Andreasen</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Skott</surname>
              <given-names>O.</given-names>
            </name>
          </person-group>
          <article-title>Differential expression of T- and L-type voltage-dependent calcium channels in renal resistance vessels</article-title>
          <source>Circ. Res.</source>
          <volume>89</volume>
          <issue>7</issue>
          <year>2001</year>
          <fpage>630</fpage>
          <lpage>638</lpage>
          <pub-id pub-id-type="pmid">11577029</pub-id>
        </element-citation>
      </ref>
      <ref id="bib22">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Harris</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Martin</surname>
              <given-names>P.E.M.</given-names>
            </name>
            <name>
              <surname>Evans</surname>
              <given-names>W.H.</given-names>
            </name>
            <name>
              <surname>Kendall</surname>
              <given-names>D.A.</given-names>
            </name>
            <name>
              <surname>Griffith</surname>
              <given-names>T.M.</given-names>
            </name>
            <name>
              <surname>Randall</surname>
              <given-names>M.D.</given-names>
            </name>
          </person-group>
          <article-title>Role of gap junctions in endothelium-derived hyperpolarizing factor responses and mechanisms of K<sup>+</sup>-relaxation</article-title>
          <source>Eur. J. Pharmacol.</source>
          <volume>402</volume>
          <issue>1–2</issue>
          <year>2000</year>
          <fpage>119</fpage>
          <lpage>128</lpage>
          <pub-id pub-id-type="pmid">10940365</pub-id>
        </element-citation>
      </ref>
      <ref id="bib23">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hill</surname>
              <given-names>M.A.</given-names>
            </name>
            <name>
              <surname>Zou</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Potocnik</surname>
              <given-names>S.J.</given-names>
            </name>
            <name>
              <surname>Meininger</surname>
              <given-names>G.A.</given-names>
            </name>
            <name>
              <surname>Davis</surname>
              <given-names>M.J.</given-names>
            </name>
          </person-group>
          <article-title>Signal transduction in smooth muscle: invited review: arteriolar smooth muscle mechanotransduction: Ca<sup>2+</sup> signaling pathways underlying myogenic reactivity</article-title>
          <source>J. Appl. Physiol.</source>
          <volume>91</volume>
          <issue>2</issue>
          <year>2001</year>
          <fpage>973</fpage>
          <lpage>983</lpage>
          <pub-id pub-id-type="pmid">11457816</pub-id>
        </element-citation>
      </ref>
      <ref id="bib24">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Huang</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Keyser</surname>
              <given-names>B.M.</given-names>
            </name>
            <name>
              <surname>Tagmose</surname>
              <given-names>T.M.</given-names>
            </name>
            <name>
              <surname>Hansen</surname>
              <given-names>J.B.</given-names>
            </name>
            <name>
              <surname>Taylor</surname>
              <given-names>J.T.</given-names>
            </name>
            <name>
              <surname>Zhuang</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Ragsdale</surname>
              <given-names>D.S.</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>NNC 55-0396 [(1 S, 2 S)-2-(2-(N-[(3-benzimidazol-2-yl)propyl]-N-methylamino)ethyl)-6-fluo ro-1, 2, 3, 4-tetrahydro-1-isopropyl-2-naphtyl cyclopropanecarboxylate dihydrochloride]: a new selective inhibitor of T-type calcium channels</article-title>
          <source>J. Pharmacol. Exp. Ther.</source>
          <volume>309</volume>
          <issue>1</issue>
          <year>2004</year>
          <fpage>193</fpage>
          <lpage>199</lpage>
          <pub-id pub-id-type="pmid">14718587</pub-id>
        </element-citation>
      </ref>
      <ref id="bib26">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jensen</surname>
              <given-names>L.J.</given-names>
            </name>
            <name>
              <surname>Holstein-Rathlou</surname>
              <given-names>N.H.</given-names>
            </name>
          </person-group>
          <article-title>Is there a role for T-type Ca<sup>2+</sup> channels in regulation of vasomotor tone in mesenteric arterioles?</article-title>
          <source>Can. J. Physiol. Pharmacol.</source>
          <volume>87</volume>
          <issue>1</issue>
          <year>2009</year>
          <fpage>8</fpage>
          <lpage>20</lpage>
          <pub-id pub-id-type="pmid">19142211</pub-id>
        </element-citation>
      </ref>
      <ref id="bib27">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jensen</surname>
              <given-names>L.J.</given-names>
            </name>
            <name>
              <surname>Salomonsson</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Jensen</surname>
              <given-names>B.L.</given-names>
            </name>
            <name>
              <surname>Holstein-Rathlou</surname>
              <given-names>N.-H.</given-names>
            </name>
          </person-group>
          <article-title>Depolarization-induced calcium influx in rat mesenteric small arterioles is mediated exclusively via mibefradil-sensitive calcium channels</article-title>
          <source>Br. J. Pharmacol.</source>
          <volume>142</volume>
          <issue>4</issue>
          <year>2004</year>
          <fpage>709</fpage>
          <lpage>718</lpage>
          <pub-id pub-id-type="pmid">15172957</pub-id>
        </element-citation>
      </ref>
      <ref id="bib28">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jewell</surname>
              <given-names>R.P.</given-names>
            </name>
            <name>
              <surname>Saundry</surname>
              <given-names>C.M.</given-names>
            </name>
            <name>
              <surname>Bonev</surname>
              <given-names>A.D.</given-names>
            </name>
            <name>
              <surname>Tranmer</surname>
              <given-names>B.I.</given-names>
            </name>
            <name>
              <surname>Wellman</surname>
              <given-names>G.C.</given-names>
            </name>
          </person-group>
          <article-title>Inhibition of Ca++ sparks by oxyhemoglobin in rabbit cerebral arteries</article-title>
          <source>J. Neurosurg.</source>
          <volume>100</volume>
          <issue>2</issue>
          <year>2004</year>
          <fpage>295</fpage>
          <lpage>302</lpage>
          <pub-id pub-id-type="pmid">15086238</pub-id>
        </element-citation>
      </ref>
      <ref id="bib29">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kaku</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>T.S.</given-names>
            </name>
            <name>
              <surname>Arita</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Hadama</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Ono</surname>
              <given-names>K.</given-names>
            </name>
          </person-group>
          <article-title>The gating and conductance properties of Cav3.2 low-voltage-activated T-type calcium channels</article-title>
          <source>Jpn J. Physiol.</source>
          <volume>53</volume>
          <issue>3</issue>
          <year>2003</year>
          <fpage>165</fpage>
          <lpage>172</lpage>
          <pub-id pub-id-type="pmid">14529577</pub-id>
        </element-citation>
      </ref>
      <ref id="bib31">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ko</surname>
              <given-names>E.A.</given-names>
            </name>
            <name>
              <surname>Han</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Jung</surname>
              <given-names>I.D.</given-names>
            </name>
            <name>
              <surname>Park</surname>
              <given-names>W.S.</given-names>
            </name>
          </person-group>
          <article-title>Physiological roles of K<sup>+</sup> channels in vascular smooth muscle cells</article-title>
          <source>J. Smooth Muscle Res.</source>
          <volume>44</volume>
          <issue>2</issue>
          <year>2008</year>
          <fpage>65</fpage>
          <lpage>81</lpage>
          <pub-id pub-id-type="pmid">18552454</pub-id>
        </element-citation>
      </ref>
      <ref id="bib32">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kobayashi</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Mori</surname>
              <given-names>Y.</given-names>
            </name>
          </person-group>
          <article-title>Ca<sup>2+</sup> channel antagonists and neuroprotection from cerebral ischemia</article-title>
          <source>Eur. J. Pharmacol.</source>
          <volume>363</volume>
          <issue>1</issue>
          <year>1998</year>
          <fpage>1</fpage>
          <lpage>15</lpage>
          <pub-id pub-id-type="pmid">9877076</pub-id>
        </element-citation>
      </ref>
      <ref id="bib33">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Koenigsberger</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Sauser</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Lamboley</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Beny</surname>
              <given-names>J.L.</given-names>
            </name>
            <name>
              <surname>Meister</surname>
              <given-names>J.J.</given-names>
            </name>
          </person-group>
          <article-title>Ca<sup>2+</sup> dynamics in a population of smooth muscle cells: modeling the recruitment and synchronization</article-title>
          <source>Biophys. J.</source>
          <volume>87</volume>
          <issue>1</issue>
          <year>2004</year>
          <fpage>92</fpage>
          <lpage>104</lpage>
          <pub-id pub-id-type="pmid">15240448</pub-id>
        </element-citation>
      </ref>
      <ref id="bib34">
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Kuo</surname>
              <given-names>I.K.</given-names>
            </name>
            <name>
              <surname>Cribbs</surname>
              <given-names>L.L.</given-names>
            </name>
            <name>
              <surname>Grayson</surname>
              <given-names>T.H.</given-names>
            </name>
          </person-group>
          <chapter-title>Expression of multiple voltage dependent calcium channels in the middle cerebral artery of adult rats</chapter-title>
          <source>9th International Symposium on Resistance Arteries (ISRA<italic>)</italic>. Hamilton Island, Australia</source>
          <year>2008</year>
        </element-citation>
      </ref>
      <ref id="bib35">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lacinova</surname>
              <given-names>L.</given-names>
            </name>
          </person-group>
          <article-title>Voltage-dependent calcium channels</article-title>
          <source>Gen. Physiol. Biophys.</source>
          <volume>24</volume>
          <issue>Suppl 1</issue>
          <year>2005</year>
          <fpage>1</fpage>
          <lpage>78</lpage>
          <pub-id pub-id-type="pmid">16096350</pub-id>
        </element-citation>
      </ref>
      <ref id="bib36">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lam</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Skarsgard</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Laher</surname>
              <given-names>I.</given-names>
            </name>
          </person-group>
          <article-title>Inhibition of myogenic tone by mibefradil in rat cerebral arteries</article-title>
          <source>Eur. J. Pharmacol.</source>
          <volume>358</volume>
          <issue>2</issue>
          <year>1998</year>
          <fpage>165</fpage>
          <lpage>168</lpage>
          <pub-id pub-id-type="pmid">9808266</pub-id>
        </element-citation>
      </ref>
      <ref id="bib37">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mandala</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Heppner</surname>
              <given-names>T.J.</given-names>
            </name>
            <name>
              <surname>Bonev</surname>
              <given-names>A.D.</given-names>
            </name>
            <name>
              <surname>Nelson</surname>
              <given-names>M.T.</given-names>
            </name>
          </person-group>
          <article-title>Effect of endogenous and exogenous nitric oxide on calcium sparks as targets for vasodilation in rat cerebral artery</article-title>
          <source>Nitric Oxide</source>
          <volume>16</volume>
          <issue>1</issue>
          <year>2007</year>
          <fpage>104</fpage>
          <lpage>109</lpage>
          <pub-id pub-id-type="pmid">16899379</pub-id>
        </element-citation>
      </ref>
      <ref id="bib38">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Marrelli</surname>
              <given-names>S.P.</given-names>
            </name>
            <name>
              <surname>O'Neil</surname>
              <given-names>R.G.</given-names>
            </name>
            <name>
              <surname>Brown</surname>
              <given-names>R.C.</given-names>
            </name>
            <name>
              <surname>Bryan</surname>
              <given-names>R.M.</given-names>
              <suffix>Jr.</suffix>
            </name>
          </person-group>
          <article-title>PLA2 and TRPV4 channels regulate endothelial calcium in cerebral arteries</article-title>
          <source>Am. J. Physiol.</source>
          <volume>292</volume>
          <year>2007</year>
          <fpage>H1390</fpage>
          <lpage>H1397</lpage>
        </element-citation>
      </ref>
      <ref id="bib39">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Martin</surname>
              <given-names>P.E.M.</given-names>
            </name>
            <name>
              <surname>Hill</surname>
              <given-names>N.S.</given-names>
            </name>
            <name>
              <surname>Kristensen</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Errington</surname>
              <given-names>R.J.</given-names>
            </name>
            <name>
              <surname>Griffith</surname>
              <given-names>T.M.</given-names>
            </name>
          </person-group>
          <article-title>Ouabain exerts biphasic effects on connexin functionality and expression in vascular smooth muscle cells</article-title>
          <source>Br. J. Pharmacol.</source>
          <volume>140</volume>
          <issue>7</issue>
          <year>2003</year>
          <fpage>1261</fpage>
          <lpage>1271</lpage>
          <pub-id pub-id-type="pmid">14645140</pub-id>
        </element-citation>
      </ref>
      <ref id="bib40">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Martin</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Villani</surname>
              <given-names>G.M.</given-names>
            </name>
            <name>
              <surname>Jothianandan</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Furchgott</surname>
              <given-names>R.F.</given-names>
            </name>
          </person-group>
          <article-title>Selective blockade of endothelium-dependent and glyceryl trinitrate-induced relaxation by hemoglobin and by methylene blue in the rabbit aorta</article-title>
          <source>J. Pharmacol. Exp. Ther.</source>
          <volume>232</volume>
          <issue>3</issue>
          <year>1985</year>
          <fpage>708</fpage>
          <lpage>716</lpage>
          <pub-id pub-id-type="pmid">2983068</pub-id>
        </element-citation>
      </ref>
      <ref id="bib41">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Matchkov</surname>
              <given-names>V.V.</given-names>
            </name>
            <name>
              <surname>Gustafsson</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Rahman</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Briggs Boedtkjer</surname>
              <given-names>D.M.</given-names>
            </name>
            <name>
              <surname>Gorintin</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Hansen</surname>
              <given-names>A.K.</given-names>
            </name>
            <name>
              <surname>Bouzinova</surname>
              <given-names>E.V.</given-names>
            </name>
            <name>
              <surname>Praetorius</surname>
              <given-names>H.A.</given-names>
            </name>
            <name>
              <surname>Aalkjaer</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Nilsson</surname>
              <given-names>H.</given-names>
            </name>
          </person-group>
          <article-title>Interaction between Na<sup>+</sup>/K<sup>+</sup>-pump and Na<sup>+</sup>/Ca<sup>2+</sup>-exchanger modulates intercellular communication</article-title>
          <source>Circ. Res.</source>
          <volume>100</volume>
          <issue>7</issue>
          <year>2007</year>
          <fpage>1026</fpage>
          <lpage>1035</lpage>
          <pub-id pub-id-type="pmid">17347477</pub-id>
        </element-citation>
      </ref>
      <ref id="bib42">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Matchkov</surname>
              <given-names>V.V.</given-names>
            </name>
            <name>
              <surname>Rahman</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Peng</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Nilsson</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Aalkjaer</surname>
              <given-names>C.</given-names>
            </name>
          </person-group>
          <article-title>Junctional and nonjunctional effects of heptanol and glycyrrhetinic acid derivates in rat mesenteric small arteries</article-title>
          <source>Br. J. Pharmacol.</source>
          <volume>142</volume>
          <issue>6</issue>
          <year>2004</year>
          <fpage>961</fpage>
          <lpage>972</lpage>
          <pub-id pub-id-type="pmid">15210581</pub-id>
        </element-citation>
      </ref>
      <ref id="bib43">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>McCarron</surname>
              <given-names>J.G.</given-names>
            </name>
            <name>
              <surname>Crichton</surname>
              <given-names>C.A.</given-names>
            </name>
            <name>
              <surname>Langton</surname>
              <given-names>P.D.</given-names>
            </name>
            <name>
              <surname>MacKenzie</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Smith</surname>
              <given-names>G.L.</given-names>
            </name>
          </person-group>
          <article-title>Myogenic contraction by modulation of voltage-dependent calcium currents in isolated rat cerebral arteries</article-title>
          <source>J. Physiol.</source>
          <volume>498</volume>
          <issue>Pt 2</issue>
          <year>1997</year>
          <fpage>371</fpage>
          <lpage>379</lpage>
          <pub-id pub-id-type="pmid">9032685</pub-id>
        </element-citation>
      </ref>
      <ref id="bib45">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>McNeish</surname>
              <given-names>A.J.</given-names>
            </name>
            <name>
              <surname>Garland</surname>
              <given-names>C.J.</given-names>
            </name>
          </person-group>
          <article-title>Thromboxane A2 inhibition of SKCa after NO synthase block in rat middle cerebral artery</article-title>
          <source>Br. J. Pharmacol.</source>
          <volume>151</volume>
          <issue>4</issue>
          <year>2007</year>
          <fpage>441</fpage>
          <lpage>449</lpage>
          <pub-id pub-id-type="pmid">17420777</pub-id>
        </element-citation>
      </ref>
      <ref id="bib46">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Moosmang</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Haider</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Bruderl</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Welling</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Hofmann</surname>
              <given-names>F.</given-names>
            </name>
          </person-group>
          <article-title>Antihypertensive effects of the putative T-type calcium channel antagonist mibefradil are mediated by the L-type calcium channel Cav1.2</article-title>
          <source>Circ. Res.</source>
          <volume>98</volume>
          <issue>1</issue>
          <year>2006</year>
          <fpage>105</fpage>
          <lpage>110</lpage>
          <pub-id pub-id-type="pmid">16306443</pub-id>
        </element-citation>
      </ref>
      <ref id="bib47">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Moosmang</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Schulla</surname>
              <given-names>V.</given-names>
            </name>
            <name>
              <surname>Welling</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Feil</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Feil</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Wegener</surname>
              <given-names>J.W.</given-names>
            </name>
            <name>
              <surname>Hofmann</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Klugbauer</surname>
              <given-names>N.</given-names>
            </name>
          </person-group>
          <article-title>Dominant role of smooth muscle L-type calcium channel Cav1.2 for blood pressure regulation</article-title>
          <source>EMBO J.</source>
          <volume>22</volume>
          <issue>22</issue>
          <year>2003</year>
          <fpage>6027</fpage>
          <lpage>6034</lpage>
          <pub-id pub-id-type="pmid">14609949</pub-id>
        </element-citation>
      </ref>
      <ref id="bib48">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Morita</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Cousins</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Onoue</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Ito</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Inoue</surname>
              <given-names>R.</given-names>
            </name>
          </person-group>
          <article-title>Predominant distribution of nifedipine-insensitive, high voltage-activated Ca<sup>2+</sup> channels in the terminal mesenteric artery of guinea pig</article-title>
          <source>Circ. Res.</source>
          <volume>85</volume>
          <issue>7</issue>
          <year>1999</year>
          <fpage>596</fpage>
          <lpage>605</lpage>
          <pub-id pub-id-type="pmid">10506484</pub-id>
        </element-citation>
      </ref>
      <ref id="bib49">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Morita</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Shi</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Ito</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Inoue</surname>
              <given-names>R.</given-names>
            </name>
          </person-group>
          <article-title>T-channel-like pharmacological properties of high voltage-activated, nifedipine-insensitive Ca<sup>2+</sup> currents in the rat terminal mesenteric artery</article-title>
          <source>Br. J. Pharmacol.</source>
          <volume>137</volume>
          <issue>4</issue>
          <year>2002</year>
          <fpage>467</fpage>
          <lpage>476</lpage>
          <pub-id pub-id-type="pmid">12359628</pub-id>
        </element-citation>
      </ref>
      <ref id="bib50">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Navarro-Gonzalez</surname>
              <given-names>M.F.</given-names>
            </name>
            <name>
              <surname>Grayson</surname>
              <given-names>T.H.</given-names>
            </name>
            <name>
              <surname>Meaney</surname>
              <given-names>K.R.</given-names>
            </name>
            <name>
              <surname>Cribbs</surname>
              <given-names>L.L.</given-names>
            </name>
            <name>
              <surname>Hill</surname>
              <given-names>C.E.</given-names>
            </name>
          </person-group>
          <article-title>Non-L-type voltage-dependent calcium channels control vascular tone of the rat basilar artery</article-title>
          <source>Clin. Exp. Pharmacol. Physiol.</source>
          <volume>36</volume>
          <issue>1</issue>
          <year>2009</year>
          <fpage>55</fpage>
          <lpage>66</lpage>
          <pub-id pub-id-type="pmid">18759855</pub-id>
        </element-citation>
      </ref>
      <ref id="bib51">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nelson</surname>
              <given-names>M.T.</given-names>
            </name>
            <name>
              <surname>Patlak</surname>
              <given-names>J.B.</given-names>
            </name>
            <name>
              <surname>Worley</surname>
              <given-names>J.F.</given-names>
            </name>
            <name>
              <surname>Standen</surname>
              <given-names>N.B.</given-names>
            </name>
          </person-group>
          <article-title>Calcium channels, potassium channels, and voltage dependence of arterial smooth muscle tone</article-title>
          <source>Am. J. Physiol. Cell Physiol.</source>
          <volume>259</volume>
          <issue>1</issue>
          <year>1990</year>
          <fpage>C3</fpage>
          <lpage>C18</lpage>
        </element-citation>
      </ref>
      <ref id="bib52">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nelson</surname>
              <given-names>M.T.</given-names>
            </name>
            <name>
              <surname>Quayle</surname>
              <given-names>J.M.</given-names>
            </name>
          </person-group>
          <article-title>Physiological roles and properties of potassium channels in arterial smooth muscle</article-title>
          <source>AmJPhysiol</source>
          <volume>268</volume>
          <issue>4 Pt 1</issue>
          <year>1995</year>
          <fpage>C799</fpage>
          <lpage>C822</lpage>
        </element-citation>
      </ref>
      <ref id="bib53">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Peng</surname>
              <given-names>H.-L.</given-names>
            </name>
            <name>
              <surname>Jensen</surname>
              <given-names>P.E.</given-names>
            </name>
            <name>
              <surname>Nilsson</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Aalkjar</surname>
              <given-names>C.</given-names>
            </name>
          </person-group>
          <article-title>Effect of acidosis on tension and [Ca<sup>2+</sup>]i in rat cerebral arteries: is there a role for membrane potential?</article-title>
          <source>Am. J. Physiol. Heart Circ. Physiol.</source>
          <volume>274</volume>
          <issue>2</issue>
          <year>1998</year>
          <fpage>H655</fpage>
          <lpage>H662</lpage>
        </element-citation>
      </ref>
      <ref id="bib54">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Peng</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Matchkov</surname>
              <given-names>V.</given-names>
            </name>
            <name>
              <surname>Ivarsen</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Aalkjaer</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Nilsson</surname>
              <given-names>H.</given-names>
            </name>
          </person-group>
          <article-title>Hypothesis for the initiation of vasomotion</article-title>
          <source>Circ. Res.</source>
          <volume>88</volume>
          <issue>8</issue>
          <year>2001</year>
          <fpage>810</fpage>
          <lpage>815</lpage>
          <pub-id pub-id-type="pmid">11325873</pub-id>
        </element-citation>
      </ref>
      <ref id="bib55">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Perez-Reyes</surname>
              <given-names>E.</given-names>
            </name>
          </person-group>
          <article-title>Molecular physiology of low-voltage-activated t-type calcium channels</article-title>
          <source>Physiol. Rev.</source>
          <volume>83</volume>
          <issue>1</issue>
          <year>2003</year>
          <fpage>117</fpage>
          <lpage>161</lpage>
          <pub-id pub-id-type="pmid">12506128</pub-id>
        </element-citation>
      </ref>
      <ref id="bib56">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pluta</surname>
              <given-names>R.M.</given-names>
            </name>
          </person-group>
          <article-title>Delayed cerebral vasospasm and nitric oxide: review, new hypothesis, and proposed treatment</article-title>
          <source>Pharmacol. Ther.</source>
          <volume>105</volume>
          <issue>1</issue>
          <year>2005</year>
          <fpage>23</fpage>
          <lpage>56</lpage>
          <pub-id pub-id-type="pmid">15626454</pub-id>
        </element-citation>
      </ref>
      <ref id="bib57">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schilling</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Eder</surname>
              <given-names>C.</given-names>
            </name>
          </person-group>
          <article-title>TRAM-34 inhibits nonselective cation channels</article-title>
          <source>Pflugers Arch</source>
          <volume>454</volume>
          <issue>4</issue>
          <year>2007</year>
          <fpage>559</fpage>
          <lpage>563</lpage>
          <pub-id pub-id-type="pmid">17318643</pub-id>
        </element-citation>
      </ref>
      <ref id="bib58">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schubert</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Lidington</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Bolz</surname>
              <given-names>S.-S.</given-names>
            </name>
          </person-group>
          <article-title>The emerging role of Ca<sup>2+</sup> sensitivity regulation in promoting myogenic vasoconstriction</article-title>
          <source>Cardiovasc. Res.</source>
          <volume>77</volume>
          <issue>1</issue>
          <year>2008</year>
          <fpage>8</fpage>
          <lpage>18</lpage>
          <pub-id pub-id-type="pmid">17764667</pub-id>
        </element-citation>
      </ref>
      <ref id="bib59">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Smirnov</surname>
              <given-names>S.V.</given-names>
            </name>
            <name>
              <surname>Aaronson</surname>
              <given-names>P.I.</given-names>
            </name>
          </person-group>
          <article-title>Ca<sup>2+</sup> currents in single myocytes from human mesenteric arteries: evidence for a physiological role of L-type channels</article-title>
          <source>J. Physiol.</source>
          <volume>457</volume>
          <issue>1</issue>
          <year>1992</year>
          <fpage>455</fpage>
          <lpage>475</lpage>
          <pub-id pub-id-type="pmid">1338463</pub-id>
        </element-citation>
      </ref>
      <ref id="bib60">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sobey</surname>
              <given-names>C.G.</given-names>
            </name>
          </person-group>
          <article-title>Potassium channel function in vascular disease</article-title>
          <source>Arterioscler. Thromb. Vasc. Biol.</source>
          <volume>21</volume>
          <issue>1</issue>
          <year>2001</year>
          <fpage>28</fpage>
          <lpage>38</lpage>
          <pub-id pub-id-type="pmid">11145930</pub-id>
        </element-citation>
      </ref>
      <ref id="bib61">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Toda</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Kawakami</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Yoshida</surname>
              <given-names>K.</given-names>
            </name>
          </person-group>
          <article-title>Constrictor action of oxyhemoglobin in monkey and dog basilar arteries in vivo and in vitro</article-title>
          <source>Am. J. Physiol. Heart Circ. Physiol.</source>
          <volume>260</volume>
          <issue>2</issue>
          <year>1991</year>
          <fpage>H420</fpage>
          <lpage>H425</lpage>
        </element-citation>
      </ref>
      <ref id="bib62">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>VanBavel</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Sorop</surname>
              <given-names>O.</given-names>
            </name>
            <name>
              <surname>Andreasen</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Pfaffendorf</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Jensen</surname>
              <given-names>B.L.</given-names>
            </name>
          </person-group>
          <article-title>Role of T-type calcium channels in myogenic tone of skeletal muscle resistance arteries</article-title>
          <source>Am. J. Physiol. Heart Circ. Physiol.</source>
          <volume>283</volume>
          <issue>6</issue>
          <year>2002</year>
          <fpage>H2239</fpage>
          <lpage>H2243</lpage>
          <pub-id pub-id-type="pmid">12388244</pub-id>
        </element-citation>
      </ref>
      <ref id="bib63">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Vanhoutte</surname>
              <given-names>P.M.</given-names>
            </name>
            <name>
              <surname>Shimokawa</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Tang</surname>
              <given-names>E.H.</given-names>
            </name>
            <name>
              <surname>Feletou</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>Endothelial dysfunction and vascular disease</article-title>
          <source>Acta Physiol (Oxf)</source>
          <volume>196</volume>
          <issue>2</issue>
          <year>2009</year>
          <fpage>193</fpage>
          <lpage>222</lpage>
          <pub-id pub-id-type="pmid">19220204</pub-id>
        </element-citation>
      </ref>
      <ref id="bib64">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Welsh</surname>
              <given-names>D.G.</given-names>
            </name>
            <name>
              <surname>Morielli</surname>
              <given-names>A.D.</given-names>
            </name>
            <name>
              <surname>Nelson</surname>
              <given-names>M.T.</given-names>
            </name>
            <name>
              <surname>Brayden</surname>
              <given-names>J.E.</given-names>
            </name>
          </person-group>
          <article-title>Transient receptor potential channels regulate myogenic tone of resistance arteries</article-title>
          <source>Circ. Res.</source>
          <volume>90</volume>
          <issue>3</issue>
          <year>2002</year>
          <fpage>248</fpage>
          <lpage>250</lpage>
          <pub-id pub-id-type="pmid">11861411</pub-id>
        </element-citation>
      </ref>
      <ref id="bib65">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wu</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Vest</surname>
              <given-names>P.A.</given-names>
            </name>
            <name>
              <surname>Bhattacharjee</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>A mibefradil metabolite is a potent intracellular blocker of L-type Ca<sup>2+</sup> currents in pancreatic beta-cells</article-title>
          <source>J. Pharmacol. Exp. Ther.</source>
          <volume>292</volume>
          <issue>3</issue>
          <year>2000</year>
          <fpage>939</fpage>
          <lpage>943</lpage>
          <pub-id pub-id-type="pmid">10688607</pub-id>
        </element-citation>
      </ref>
      <ref id="bib66">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wyatt</surname>
              <given-names>C.N.</given-names>
            </name>
            <name>
              <surname>Page</surname>
              <given-names>K.M.</given-names>
            </name>
            <name>
              <surname>Berrow</surname>
              <given-names>N.S.</given-names>
            </name>
            <name>
              <surname>Brice</surname>
              <given-names>N.L.</given-names>
            </name>
            <name>
              <surname>Dolphin</surname>
              <given-names>A.C.</given-names>
            </name>
          </person-group>
          <article-title>The effect of overexpression of auxiliary Ca<sup>2+</sup> channel subunits on native Ca<sup>2+</sup> channel currents in undifferentiated mammalian NG108-15 cells</article-title>
          <source>J. Physiol.</source>
          <volume>510</volume>
          <issue>Pt 2</issue>
          <year>1998</year>
          <fpage>347</fpage>
          <lpage>360</lpage>
          <pub-id pub-id-type="pmid">9705988</pub-id>
        </element-citation>
      </ref>
      <ref id="bib67">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yuill</surname>
              <given-names>K.H.</given-names>
            </name>
            <name>
              <surname>McNeish</surname>
              <given-names>A.J.</given-names>
            </name>
            <name>
              <surname>Kansui</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Garland</surname>
              <given-names>C.J.</given-names>
            </name>
            <name>
              <surname>Dora</surname>
              <given-names>K.A.</given-names>
            </name>
          </person-group>
          <article-title>Nitric oxide suppresses cerebral vasomotion by sGC-independent effects on ryanodine receptors and voltage-gated calcium channels</article-title>
          <source>J. Vasc. Res.</source>
          <volume>47</volume>
          <issue>2</issue>
          <year>2010</year>
          <fpage>93</fpage>
          <lpage>107</lpage>
          <pub-id pub-id-type="pmid">19729956</pub-id>
        </element-citation>
      </ref>
      <ref id="bib68">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zimmermann</surname>
              <given-names>P.A.</given-names>
            </name>
            <name>
              <surname>Knot</surname>
              <given-names>H.J.</given-names>
            </name>
            <name>
              <surname>Stevenson</surname>
              <given-names>A.S.</given-names>
            </name>
            <name>
              <surname>Nelson</surname>
              <given-names>M.T.</given-names>
            </name>
          </person-group>
          <article-title>Increased myogenic tone and diminished responsiveness to ATP-sensitive K<sup>+</sup> channel openers in cerebral arteries from diabetic rats</article-title>
          <source>Circ. Res.</source>
          <volume>81</volume>
          <issue>6</issue>
          <year>1997</year>
          <fpage>996</fpage>
          <lpage>1004</lpage>
          <pub-id pub-id-type="pmid">9400380</pub-id>
        </element-citation>
      </ref>
    </ref-list>
    <ack>
      <title>Acknowledgments</title>
      <p>The research was supported by the Wellcome Trust and BHF. Francesc Jiminez-Altayo and Alister McNeish contributed equally. A.J.M is a BHF Intermediate Fellow, FJA was supported by the Ministerio de Educación y Ciencia and C.J.G is a Royal Society-Wolfson Research Merit Award holder.</p>
    </ack>
  </back>
  <floats-group>
    <fig id="fig1">
      <label>Fig. 1</label>
      <caption>
        <p>Original traces showing simultaneous recordings of membrane potential (upper panels) and tension (lower panels) in rat middle cerebral arteries under control resting conditions (A) or in the presence of L-NAME (100 μM), indomethacin (10 μM) and iberiotoxin (100 mN; B). Under control conditions, membrane potential and tension are relatively stable. In the presence of L-NAME, indomethacin and iberiotoxin, the smooth muscle cells depolarized and developed regular depolarizing oscillations, which were associated with constriction and oscillations in tension; the peaks in membrane potential immediately preceded peaks in tension. Decreasing extracellular calcium (from 2.5 to 0 mM Ca<sup>2+</sup>) caused depolarization and relaxation. Average data are shown in (C and D) showing the oscillation amplitude in membrane potential (C) and tension (D) in control vessels (2.5 mM Ca<sup>2+</sup>) and in the presence of 1, 0.5, 0.25 and 0 mM Ca<sup>2+</sup>. Data expressed as means ± S.E.M. * <italic>P</italic> ≤ 0.05 indicates a significant difference from control by one-way ANOVA with Tukey's post-hoc test, n = 3–7.</p>
      </caption>
      <graphic xlink:href="gr1"/>
    </fig>
    <fig id="fig2">
      <label>Fig. 2</label>
      <caption>
        <p>Original traces showing the effect of either (A) the T-type Ca<sup>2+</sup> channel blocker, mibefradil (100 nM), (B) the more selective T-type Ca<sup>2+</sup> channel antagonist, NNC 55-0396 (300 nM) or (C) the combined application of NNC 55-0396 (300 nM) and the L-type Ca<sup>2+</sup> channel blocker, nifedipine (1 μM), on simultaneous recordings of membrane potential (upper panels) and tension (lower panels). Both mibefradil and NNC 55-0396 caused relaxation and abolished oscillations in membrane potential and tension; combined application of NNC 55-0396 and nifedipine caused greater hyperpolarization and relaxation than NNC-550396 alone, n = 4–6. Parallel lines (//) indicate a time break between same recordings from a single vessel the first time break shows the response at approximately 5 min post addition of drug the second time break corresponds to the maximum response which is approximately 15 min following addition.</p>
      </caption>
      <graphic xlink:href="gr2"/>
    </fig>
    <fig id="fig3">
      <label>Fig. 3</label>
      <caption>
        <p>Original traces showing control conditions (A), the effect of the K<sub>Ca</sub>3.1 channel blocker, TRAM-34 (1 μM; B), the K<sub>Ca</sub>2.3 channel blocker, apamin (50 nM; C) or the combined application of TRAM-34 and apamin (D) on simultaneous recordings of membrane potential (upper panels) and tension (lower panels). Average data for oscillation amplitude in membrane potential (left panel) and tension (right panel) in control vessels and in the presence of TRAM-34, apamin and TRAM-34 + apamin are also shown (E). Data are expressed as means ± S.E.M. * <italic>P</italic> ≤ 0.05 indicates a significant difference from control by one-way ANOVA with Tukey's post-hoc test, n = 3–9.</p>
      </caption>
      <graphic xlink:href="gr3"/>
    </fig>
    <fig id="fig4">
      <label>Fig. 4</label>
      <caption>
        <p>Original traces showing control conditions (A) and the effect of either the BK<sub>Ca</sub> and K<sub>Ca</sub>3.1 channel blocker, charybdotoxin (100 nM; B) or the combined application of charybdotoxin (100 nM) and the K<sub>Ca</sub>2.3 channel blocker, apamin (50 nM; C) on simultaneous recordings of membrane potential (upper panels) and tension (lower panels). Average data are shown for the oscillation amplitude in membrane potential (D) and tension (E) in control vessels and in the presence of charybdotoxin and charybdotoxin + apamin. Data expressed as means ± S.E.M. n = 3–4.</p>
      </caption>
      <graphic xlink:href="gr4"/>
    </fig>
    <fig id="fig5">
      <label>Fig. 5</label>
      <caption>
        <p>Original traces showing (A) the effect of the voltage-gated K<sup>+</sup>channel inhibitor, 4-AP (3 mM) and (B) the effect of the Na<sup>+</sup>/K<sup>+</sup>-ATPase inhibitor, ouabain (1 μM) on simultaneous recordings of membrane potential (upper panels) and tension (lower panels). Average data are shown in (C) showing the oscillation amplitude in membrane potential (left panel) and tension (right panel) in control vessels and in the presence of ouabain and ouabain + 4-AP. Data expressed as means ± S.E.M. */<sup><bold>+</bold></sup><italic>P</italic> ≤ 0.05 indicates a significant difference from either control or from ouabain alone, respectively, using one-way ANOVA with Tukey's post-hoc test, n = 3.</p>
      </caption>
      <graphic xlink:href="gr5"/>
    </fig>
  </floats-group>
</article>